Effects of genistein aglycone in glucocorticoid induced osteoporosis: A randomized clinical trial in comparison with alendronate

Effects of genistein aglycone in glucocorticoid induced osteoporosis: A randomized clinical trial in comparison with alendronate

Glucocorticoid-induced osteoporosis (GIO) complicates the clinical management of patients subjected to long-term glucocorticoid use. This study explored the effects of genistein on bone loss in a randomized double-blind alendronate-controlled trial in postmenopausal women with GIO. 200 postmenopausa...

Full description

Bibliographic Details
Main Authors: Francesco Squadrito, Egidio Imbalzano, Michelangelo Rottura, Vincenzo Arcoraci, Giovanni Pallio, Antonino Catalano, Marco Atteritano, Natasha Irrera, Federica Mannino, Giovanni Squadrito, Mario Vaccaro, Pierangela Irrera, Igor Pirrotta, Alessandra Bitto
Format: Article
Language:English
Published: Elsevier 2023-07-01
Series:Biomedicine & Pharmacotherapy
Subjects:
Bone remodeling
Clinical trials
Genistein
Osteoporosis
Online Access:http://www.sciencedirect.com/science/article/pii/S075333222300611X

Similar Items

Similar Items